Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 205

1.

Raf-1 kinase inhibitor protein: structure, function, regulation of cell signaling, and pivotal role in apoptosis.

Odabaei G, Chatterjee D, Jazirehi AR, Goodglick L, Yeung K, Bonavida B.

Adv Cancer Res. 2004;91:169-200. Review.

PMID:
15327891
2.

Raf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activation.

Yeung KC, Rose DW, Dhillon AS, Yaros D, Gustafsson M, Chatterjee D, McFerran B, Wyche J, Kolch W, Sedivy JM.

Mol Cell Biol. 2001 Nov;21(21):7207-17.

3.
4.

Protein kinase C switches the Raf kinase inhibitor from Raf-1 to GRK-2.

Lorenz K, Lohse MJ, Quitterer U.

Nature. 2003 Dec 4;426(6966):574-9.

PMID:
14654844
6.

Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry.

Bonavida B, Baritaki S.

Nitric Oxide. 2011 Jan 1;24(1):1-7. doi: 10.1016/j.niox.2010.10.001. Epub 2010 Oct 8. Review.

PMID:
20933602
7.
8.

The anti-CD20 mAb LFB-R603 interrupts the dysregulated NF-κB/Snail/RKIP/PTEN resistance loop in B-NHL cells: role in sensitization to TRAIL apoptosis.

Baritaki S, Militello L, Malaponte G, Spandidos DA, Salcedo M, Bonavida B.

Int J Oncol. 2011 Jun;38(6):1683-94. doi: 10.3892/ijo.2011.984. Epub 2011 Mar 23.

PMID:
21455568
9.

Raf kinase inhibitory protein regulates aurora B kinase and the spindle checkpoint.

Eves EM, Shapiro P, Naik K, Klein UR, Trakul N, Rosner MR.

Mol Cell. 2006 Aug;23(4):561-74.

10.

Suppression of Raf-1 kinase activity and MAP kinase signalling by RKIP.

Yeung K, Seitz T, Li S, Janosch P, McFerran B, Kaiser C, Fee F, Katsanakis KD, Rose DW, Mischak H, Sedivy JM, Kolch W.

Nature. 1999 Sep 9;401(6749):173-7.

PMID:
10490027
11.

Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization.

Baritaki S, Yeung K, Palladino M, Berenson J, Bonavida B.

Cancer Res. 2009 Nov 1;69(21):8376-85. doi: 10.1158/0008-5472.CAN-09-1069. Epub 2009 Oct 20.

12.
13.

Raf kinase inhibitor protein mediated signaling inhibits invasion and metastasis of hepatocellular carcinoma.

Wu X, Yang Y, Xu Z, Li J, Yang B, Feng N, Zhang Y, Wang S.

Biochim Biophys Acta. 2016 Feb;1860(2):384-91. doi: 10.1016/j.bbagen.2015.06.009. Epub 2015 Jun 25.

PMID:
26116914
14.

What signals are generated by anti-CD20 antibody therapy?

Bonavida B.

Curr Hematol Malig Rep. 2006 Dec;1(4):205-13. doi: 10.1007/s11899-006-0001-z. Review.

PMID:
20425315
15.
18.

Dysregulation of the cell survival/anti-apoptotic NF-kappaB pathway by the novel humanized BM-ca anti-CD20 mAb: implication in chemosensitization.

Vega MI, Martínez-Paniagua M, Huerta-Yepez S, González-Bonilla C, Uematsu N, Bonavida B.

Int J Oncol. 2009 Dec;35(6):1289-96.

PMID:
19885551
19.

Blocking the Raf/MEK/ERK pathway sensitizes acute myelogenous leukemia cells to lovastatin-induced apoptosis.

Wu J, Wong WW, Khosravi F, Minden MD, Penn LZ.

Cancer Res. 2004 Sep 15;64(18):6461-8.

20.

Raf kinase inhibitor protein regulation of raf and MAPK signaling.

Hagan S, Garcia R, Dhillon A, Kolch W.

Methods Enzymol. 2006;407:248-59.

PMID:
16757329

Supplemental Content

Support Center